Shimada Tadahito, Yoneda Masashi, Hiraishi Hideyuki, Terano Akira
Department of Gastroenterology, Dokkyo University School of Medicine.
Nihon Rinsho. 2003 Jan;61(1):7-12.
Helicobacter pylori(H. pylori) is a causative agent for chronic gastritis and is an important risk factor for peptic ulcers, gastric carcinomas, and gastric MALT lymphomas. In 2000, the Japanese Society for Helicobacter Research published a guideline on the diagnosis and treatment of H. pylori infection for physicians in routine medical practice. In this guideline, H. pylori eradication therapy is recommended in gastric or duodenal ulcer patients. H. pylori eradication is also recommended in gastric MALT lymphoma patients but the guideline says it should be done at specialist institutions. Considering the high prevalence of gastric carcinomas in Japan. H. pylori eradication for the prevention of gastric carcinomas should be discussed urgently.
幽门螺杆菌（H. pylori）是慢性胃炎的病原体，也是消化性溃疡、胃癌和胃黏膜相关淋巴组织淋巴瘤的重要危险因素。2000年，日本幽门螺杆菌研究学会为从事常规医疗工作的医生发布了一份关于幽门螺杆菌感染诊断和治疗的指南。在该指南中，建议对胃溃疡或十二指肠溃疡患者进行幽门螺杆菌根除治疗。对于胃黏膜相关淋巴组织淋巴瘤患者也建议进行幽门螺杆菌根除治疗，但指南指出应在专科医院进行。鉴于日本胃癌的高发病率，应紧急讨论通过根除幽门螺杆菌来预防胃癌的问题。
